I had an exciting and informative discussion with Conor Walsh, Co-Founder of Imago Rehab and founder of Harvard Biodesign Lab. Conor, who holds a PhD from Massachusetts Institute of Technology and is a professor in Engineering and Applied Science at Harvard University, discussed his research on developing innovative robotic technologies to improve human performance. He explained how the Imago technology was conceived and his work with soft flexible robotic systems that could revolutionize health and rehabilitation.

Frank Bonnet, the founder and CEO of Bionomous - a robotics startup - shares his insights on Tech Talks. They are currently working on an innovative project that automates the sorting and categorization of zebrafish, a widely-used process in clinical research due to its similar genetic structure to humans. The conversation is engaging, and Frank and his team are definitely a company worth watching.

Rob Eno, President of HeartBeam Inc., discussed the rapid evolution of technology and clinical care in a recent chat. He highlighted the excitement of this platform technology and will discuss further in the #TechTalks Podcast next week.

The medical device industry is supposed to be hard. We have patients relying on the trust of our clinicians, governing bodies, and manufacturers to put them first. This conversation with Mark A. Turco, M.D., F.A.C.C. , CEO of JC Medical, Inc. and President, Genesis Intervention, highlights so much of why we are focused in innovation in this industry.

In a recent chat with Marissa Fayer, CEO of DeepLook Medical and non-profit HERhealthEQ, Marissa shared how the importance of awareness and attention on the issues with women in focus, and how her companies are pioneering new trails for better healthcare.

A successful startup requires customized support. That is exactly what Paul Grand, CEO MedTech Innovator, shared in our chat on TechTalks. The power of MedTech Innovator lies in the resources.

AdvaMed is the world's largest medical technology association representing device, diagnostics and digital technology companies. In the last 10 years, the FDA has been navigating new roads for innovative technologies with a digital component. The need for a focused effort within this organization was loud and clear, and this charter is exactly what attracted Shaye Mandle, Executive Director, to lead Advamed's Center for Digital Health. 

In a recent chat with Desmond Adler, President of Cardiovascular for Gentuity, LLC, Desmond shared how he was drawn to the #OCT (optical coherence tomography) platform of Gentuity because he came from a substantial background of its use in #opthalmology. Optical coherence tomography (OCT) is noninvasive imaging method that uses reflected light to diagnose and manage diseases that can produce fast and accurate images of the coronary vessels.

Holly and Rene van der Merwe, Chief Medical Officer and Head of Clinical Development at Galvani Bioelectronics, discuss the approach of Galvani Bioelectronics. Rather than targeting the vagus nerve, Galvani targets nerve bundles of the spleen. Rene shares an analogy of a "telephone exchange", where targeting the vagus nerve is like tapping into telephone poles, and through these wires your call must be directed throughout many of the downstream pathways. With so many challenging diseases stemming from inflammatory response, it is clear why Rene and the Galvani team are passionate about their continued momentum. 

Manisha Shah-Bugaj, CEO of Activ Surgical, and Holly Scott discuss the surgical navigation platform of Activ and its tremendous potential to reduce surgical error.